see full prescribing information for conversion to monotherapy (2.1) Absence Seizures: Start at 15 mg/kg/day, increasing at 1 week intervals by 5 to 10 mg/kg/day until seizure control or limiting side effects (2.1) Dosage Forms and Strengths Capsules: 125 mg (3) Contraindications Hepatic disease or significant hepatic dysfunction (4,5.1) Known mitochondrial disorders caused by mutations in mitochondrial DNA polymerase (POLG) (4, 5.1) Suspected POLG-related disorder in children under two years of age (4, 5.1) Known hypersensitivity to the drug (4,5.12) Urea cycle disorders (4, 5.6) Prophylaxis of migraine headaches: Pregnant women, women of childbearing potential not using effective contraception (4,8.1) Warnings and Precautions Birth defects, decreased IQ, and neurodevelopmental disorders following in uteroexposure: should not be used to treat women with epilepsy or bipolar disorder who are pregnant or who plan to become pregnant or to treat a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable (5.2, 5.3, 5.4) Pancreatitis: divalproex sodium delayed-release capsules should ordinarily be discontinued (5.5) Suicidal behavior or ideation: Antiepileptic drugs, including divalproex sodium delayed-release capsules increase the risk of suicidal thoughts or behavior (5.7) Bleeding and other hematopoietic disorders: monitor platelet counts and coagulation tests (5.8) Hyperammonemia and hyperammonemic encephalopathy: measure ammonia level if unexplained lethargy and vomiting or changes in mental status, and also with concomitant topiramate use
DNMT1-driven methylation of RORA facilitates esophageal squamous cell carcinoma progression under hypoxia through SLC2A3
doi: 10.5301/JE.5000151
Theyre crafted without animal-derived ingredients, making them completely vegetarian-friendly.
Helps Restore Metabolic Function
